Tenet Healthcare (THC) Tops Q3 EPS by 58c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Wolfe Research Reiterates Outperform Rating on Tenet Healthcare (THC)
October 29, 2024 10:08 AM EDTWolfe Research analyst Justin Lake reiterated an Outperform rating and $178.00 price target on Tenet Healthcare (NYSE: THC).
The analyst comments "THC 3Q24 Beat on Strong SS Volume / Revenue Growth in Hospitals - THC reported 3Q24 rev of $5.12B, up 1.2% y/y ~1% above expectations. Adj. EBITDA of $978M up... More
